Litigation Details for Shire Development LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Shire Development LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-11-22 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 6,913,768; 8,846,100; 9,173,857 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Shire Development LLC v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Shire Development LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-02-28 | 109 | in U.S. Patent Nos. 6,913,768 ('"768 Patent"), 8,846,100 ("'100 Patent"),…construction for multiple terms in U.S. Patent Nos. 6,913,768, 8,846,100, and 9,173,857. Within five …claim 1 of the ' 100 Patent and claim 1 of the ' 857 Patent. The Patents relate to "a long-acting…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
